Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2017-01-31 Board/Management Inform…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Valg af medarbejderrepræsentanter til bestyrelsen i Novozymes A/S
Board/Management Information Classification · 100% confidence The document is a corporate announcement regarding the election of employee representatives to the Board of Directors of Novozymes A/S. It lists the names of the elected individuals and their roles, which directly pertains to changes or updates in the composition of the board. According to the provided definitions, announcements regarding changes in the company's board of directors fall under the 'MANG' (Board/Management Information) category.
2017-01-31 English
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 98% confidence The document is a corporate announcement (Selskabsmeddelelse nr. 7, dated January 30, 2017) detailing transactions conducted under Novozymes' share buy-back program ('aktietilbagekøbsprogram'). It explicitly lists the number of shares purchased, transaction values, and includes detailed appendix tables of individual trades. This content directly relates to the company acquiring its own shares, which matches the definition for 'Transaction in Own Shares' (POS). It is not a general regulatory filing (RNS) because it is highly specific to share repurchase activity, nor is it a general capital change (SHA), which is broader. The key phrase is 'Transaktioner i forbindelse med Novozymes' aktietilbagekøbsprogram' and the detailed trade logs.
2017-01-30 Danish
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 99% confidence The document explicitly discusses 'Transactions under Novozymes' stock buyback program' and details the number of shares purchased, transaction values, and specific dates (January 25 to January 27, 2017). This content directly relates to the company repurchasing its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). It is not an earnings release, an annual report, or a general regulatory filing, but a specific disclosure about share repurchase activity.
2017-01-30 English
Report Publication Announcement 2017
Report Publication Announcement Classification · 95% confidence The document text is extremely short ("Please read the invitation in PDF format") and explicitly directs the reader to an external document (an 'invitation' in PDF format). This strongly suggests the current document is merely an announcement or cover page pointing to the main content, rather than the content itself. Given the options, this fits best as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since 'invitation' often relates to meetings or official releases, RPA is a strong candidate, but RNS is the general fallback for short announcements. Given the brevity and the instruction to read an attached/linked document, RPA (Report Publication Announcement) is the most appropriate classification for announcing the availability of an official document/invitation.
2017-01-27 English
AGM Information 2017
AGM Information Classification · 98% confidence The document is explicitly titled "Invitation Annual shareholders' meeting 2017" and details the agenda for the meeting, including proposals for approving the annual report, dividend distribution, changes to remuneration guidelines, capital reduction, authorization to acquire treasury shares, and election of board members and auditor. This content is characteristic of the materials distributed to shareholders in advance of an Annual General Meeting (AGM) to inform their voting decisions. The specific mention of proposals regarding remuneration (Item 4 & 5) and capital structure changes (Item 6) strongly suggests this is a proxy or information statement related to the AGM, but the primary context is the meeting invitation and agenda itself. The closest fit among the provided codes is AGM-R (AGM Information) or potentially PSI (Proxy Solicitation & Information Statement). Since it is an invitation detailing the agenda and proposals to be voted on, AGM-R is the most direct classification for the meeting materials themselves, although PSI is also highly relevant for the voting aspect. Given the structure as an 'Invitation' with an 'Agenda' and detailed proposals, AGM-R is selected as the primary type.
2017-01-27 English
Indkaldelse til Novozymes A/S generalforsamling 2017
Proxy Solicitation & Information Statement Classification · 100% confidence The document is an official invitation to the Novozymes Annual General Meeting (Generalforsamling) for 2017. It contains the agenda, proposals for board elections, remuneration guidelines, and instructions for shareholders regarding voting and attendance. This document is a classic proxy statement/notice of meeting sent to shareholders to solicit their participation and votes.
2017-01-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.